retatrutide parkinson's Promises Big Weight Loss, but Safety Remains a Question GLP-1 Agonists: A New Frontier

DPP-4 inhibitors are body weight neutral and they have demonstrated cardiovascular safety

Patients with certain GLP1R variants experience more marked appetite suppression and gastric changes, which could intensify antibiotic absorption concerns

Diabetes 49:11561164

By addressing the underlying causes of obesity, surgery eliminates the need for medications and their associated side effects, helping patients achieve better health outcomes without the constant risk of complications

Healthcare providers consider various factors when establishing the right dose for a patient

But that same mechanism means oral medications sit in your stomach for hours instead of being absorbed in 30 minutes